BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 11776031)

  • 1. Adjuvant chemotherapy following radical surgery for non-small-cell lung cancer: a randomized study on 70 patients.
    Xu G; Rong T; Lin P
    Chin Med J (Engl); 2000 Jul; 113(7):617-20. PubMed ID: 11776031
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Adjuvant chemotherapy following radical surgery for non-small cell lung cancer: a randomized study].
    Xu G; Rong T; Lin P
    Zhonghua Zhong Liu Za Zhi; 1998 May; 20(3):228-30. PubMed ID: 10921016
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Postoperative adjuvant cisplatin, vindesine, plus uracil-tegafur chemotherapy increased survival of patients with completely resected p-stage I non-small cell lung cancer.
    Imaizumi M;
    Lung Cancer; 2005 Jul; 49(1):85-94. PubMed ID: 15949594
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Postoperative adjuvant chemotherapy for stage I non-small cell lung cancer.
    Park JH; Lee CT; Lee HW; Baek HJ; Zo JI; Shim YM
    Eur J Cardiothorac Surg; 2005 Jun; 27(6):1086-91. PubMed ID: 15896623
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Surgical treatment for limited small-cell lung cancer. The University of Toronto Lung Oncology Group experience.
    Shepherd FA; Ginsberg RJ; Feld R; Evans WK; Johansen E
    J Thorac Cardiovasc Surg; 1991 Mar; 101(3):385-93. PubMed ID: 1847981
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [A randomized controlled study of post-operative adjuvant therapy in non-small cell lung cancer].
    Fukushima M; Tsushima T; Ito H; Fukuda Y; Maruyama A; Fujita H; Yagihashi N; Tsuge T; Ishioka T; Kudo T; Kishibe S; Sato T; Machida S; Kogawa R; Takashima K; Koie H; Fujita K
    Gan To Kagaku Ryoho; 1996 Feb; 23(3):303-9. PubMed ID: 8712823
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A randomized trial comparing induction chemotherapy followed by surgery with surgery alone for patients with stage IIIA N2 non-small cell lung cancer (JCOG 9209).
    Nagai K; Tsuchiya R; Mori T; Tada H; Ichinose Y; Koike T; Kato H;
    J Thorac Cardiovasc Surg; 2003 Feb; 125(2):254-60. PubMed ID: 12579093
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A prospective study of adjuvant surgical resection after chemotherapy for limited small cell lung cancer. A University of Toronto Lung Oncology Group study.
    Shepherd FA; Ginsberg RJ; Patterson GA; Evans WK; Feld R
    J Thorac Cardiovasc Surg; 1989 Feb; 97(2):177-86. PubMed ID: 2536868
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Symptomatic treatment versus combination chemotherapy in advanced non-small cell lung cancer].
    Xu G; Liu G
    Zhonghua Zhong Liu Za Zhi; 1999 Jan; 21(1):60-2. PubMed ID: 11776801
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of neoadjuvant cisplatin-based chemotherapy versus radiochemotherapy followed by resection for stage III (N2) NSCLC.
    Pezzetta E; Stupp R; Zouhair A; Guillou L; Taffé P; von Briel C; Krueger T; Ris HB
    Eur J Cardiothorac Surg; 2005 Jun; 27(6):1092-8. PubMed ID: 15896624
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Postoperative adjuvant treatment for non-small cell lung cancer].
    Ichinose Y
    Gan To Kagaku Ryoho; 2002 Dec; 29(13):2470-4. PubMed ID: 12506468
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Combination chemotherapy with Taxol and cisplatin for 57 patients with non-small cell lung cancer by intraartery and intravenous infusion].
    Zhao Y; Wang SM; Zhang J
    Ai Zheng; 2002 Dec; 21(12):1365-7. PubMed ID: 12520750
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adjuvant chemotherapy for radically resected non-small cell lung cancer: a retrospective analysis of 311 consecutively treated patients.
    Dediu M; Horvat T; Tarlea A; Anghel R; Cordos I; Miron G; Iorga P; Alexandru A; Nistor C; Grozavu C; Savu C
    Lung Cancer; 2005 Jan; 47(1):93-101. PubMed ID: 15603859
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Concurrent cisplatin/etoposide plus 3D-conformal radiotherapy followed by surgery for stage IIB (superior sulcus T3N0)/III non-small cell lung cancer yields a high rate of pathological complete response.
    Pourel N; Santelmo N; Naafa N; Serre A; Hilgers W; Mineur L; Molinari N; Reboul F
    Eur J Cardiothorac Surg; 2008 May; 33(5):829-36. PubMed ID: 18367406
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Randomized controlled trial of resection versus radiotherapy after induction chemotherapy in stage IIIA-N2 non-small-cell lung cancer.
    van Meerbeeck JP; Kramer GW; Van Schil PE; Legrand C; Smit EF; Schramel F; Tjan-Heijnen VC; Biesma B; Debruyne C; van Zandwijk N; Splinter TA; Giaccone G;
    J Natl Cancer Inst; 2007 Mar; 99(6):442-50. PubMed ID: 17374834
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adjuvant chemotherapy for completely resected stage III non-small-cell lung cancer. Results of a randomized prospective study. The Japan Clinical Oncology Group.
    Ohta M; Tsuchiya R; Shimoyama M; Sawamura K; Mori T; Miyazawa N; Suemasu K; Watanabe Y; Tomita M; Terashima M
    J Thorac Cardiovasc Surg; 1993 Oct; 106(4):703-8. PubMed ID: 8412266
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Predicting efficacy of neoadjuvant cheomotherapy on resectable stage IIIA non-small cell lung cancer by multi-gene expressions].
    Cheng C; Wu YL; Gu LJ; Chen G; Weng YM; Feng WN; Zhong WZ
    Ai Zheng; 2005 Jul; 24(7):846-9. PubMed ID: 16004813
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Compliance with post-operative adjuvant chemotherapy in non-small cell lung cancer. An analysis of National Cancer Institute of Canada and intergroup trial JBR.10 and a review of the literature.
    Alam N; Shepherd FA; Winton T; Graham B; Johnson D; Livingston R; Rigas J; Whitehead M; Ding K; Seymour L
    Lung Cancer; 2005 Mar; 47(3):385-94. PubMed ID: 15713522
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Compliance with adjuvant chemotherapy in non-small cell lung cancer. The experience of a single institution evaluating a cohort of 356 patients.
    Dediu M; Alexandru A; Median D; Anghel R; Tarlea A; Iorga P; Movanu M
    J BUON; 2006; 11(4):425-32. PubMed ID: 17309173
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cisplatin plus weekly vinorelbine versus cisplatin plus vinorelbine on days 1 and 8 in advanced non-small cell lung cancer: a prospective randomized phase III trial of the G.O.I.M. (Gruppo Oncologico Italia Meridionale).
    Gebbia V; Galetta D; Lorusso V; Caruso M; Verderame F; Pezzella G; Borsellino N; Durini E; Valenza R; Agostara B; Colucci G;
    Lung Cancer; 2008 Sep; 61(3):369-77. PubMed ID: 18308419
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.